|Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications|
S Sen, R Duman, G Sanacora
Biological psychiatry 64 (6), 527-532, 2008
|The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission|
M Popoli, Z Yan, BS McEwen, G Sanacora
Nature Reviews Neuroscience 13 (1), 22-37, 2012
|Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders|
G Sanacora, CA Zarate, JH Krystal, HK Manji
Nature reviews Drug discovery 7 (5), 426-437, 2008
|Subtype-specific alterations of γ-aminobutyric acid and glutamatein patients with major depression|
G Sanacora, R Gueorguieva, CN Epperson, YT Wu, M Appel, ...
Archives of general psychiatry 61 (7), 705-713, 2004
|Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders|
G Sanacora, G Treccani, M Popoli
Neuropharmacology 62 (1), 63-77, 2012
|Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants|
RS Duman, GK Aghajanian, G Sanacora, JH Krystal
Nature medicine 22 (3), 238-249, 2016
|Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy|
G Sanacora, GF Mason, DL Rothman, KL Behar, F Hyder, OAC Petroff, ...
Archives of general psychiatry 56 (11), 1043-1047, 1999
|Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl) tropane and single photon emission computed tomography|
RT Malison, LH Price, R Berman, CH Van Dyck, GH Pelton, L Carpenter, ...
Biological psychiatry 44 (11), 1090-1098, 1998
|Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments|
JH Krystal, G Sanacora, H Blumberg, A Anand, DS Charney, G Marek, ...
Molecular psychiatry 7 (1), S71-S80, 2002
|Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors|
G Sanacora, GF Mason, DL Rothman, JH Krystal
American Journal of Psychiatry 159 (4), 663-665, 2002
|A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression|
RM Berman, M Narasimhan, G Sanacora, AP Miano, RE Hoffman, XS Hu, ...
Biological psychiatry 47 (4), 332-337, 2000
|Increased cortical GABA concentrations in depressed patients receiving ECT|
G Sanacora, GF Mason, DL Rothman, F Hyder, JJ Ciarcia, RB Ostroff, ...
American Journal of Psychiatry 160 (3), 577-579, 2003
|Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole|
M Banasr, GMI Chowdhury, R Terwilliger, SS Newton, RS Duman, ...
Molecular psychiatry 15 (5), 501-511, 2010
|Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond|
JH Krystal, G Sanacora, RS Duman
Biological psychiatry 73 (12), 1133-1141, 2013
|Riluzole augmentation in treatment-resistant obsessive–compulsive disorder: an open-label trial|
V Coric, S Taskiran, C Pittenger, S Wasylink, DH Mathalon, G Valentine, ...
Biological psychiatry 58 (5), 424-428, 2005
|Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus|
B Bhat, N Bhat, AB Eldrup, TP Prakash, M Prhavc, Q Song, PD Cook, ...
US Patent 6,777,395, 2004
|Beyond monoamines: glutamatergic function in mood disorders|
A Kugaya, G Sanacora
CNS spectrums 10 (10), 808-819, 2005
|The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis|
ST Wilkinson, ED Ballard, MH Bloch, SJ Mathew, JW Murrough, A Feder, ...
American journal of psychiatry 175 (2), 150-158, 2018
|A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression|
JB Singh, M Fedgchin, EJ Daly, P De Boer, K Cooper, P Lim, C Pinter, ...
American Journal of Psychiatry 173 (8), 816-826, 2016
|Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics|
CG Abdallah, G Sanacora, RS Duman, JH Krystal
Annual review of medicine 66, 509-523, 2015